Screener
PJP vs RFG
Invesco Pharmaceuticals ETF vs Invesco S&P MidCap 400 Pure Growth ETF
Key differences
- RFG costs 0.22% less per year.
- Over the last 3 years, RFG has delivered higher annualized returns.
Side-by-side comparison
| PJP | RFG | |
|---|---|---|
| Annual cost (TER) | 0.57% | 0.35% |
| Fund size (AUM) | $334M | $329M |
| Since | 2005 | 2006 |
| Dividend yield | 1.01% | 0.34% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +40.6% | +34.2% |
| CAGR 3Y | +14.0% | +20.3% |
| CAGR 5Y | +7.8% | +8.6% |
| Sharpe 3Y | 0.69 | 0.84 |
| Volatility 1Y | 16.23% | 18.65% |
| Max drawdown | -33.95% | -42.92% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PJP and RFG
Explore further